IMRX
Immuneering Corp - Ordinary Shares Class A

2,079
Loading...
Loading...
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
66

Frequently Asked Questions

What is Market Cap of Immuneering Corp - Ordinary Shares Class A?
What is the 52-week high for Immuneering Corp - Ordinary Shares Class A?
What is the 52-week low for Immuneering Corp - Ordinary Shares Class A?
What is Immuneering Corp - Ordinary Shares Class A stock price today?
What was Immuneering Corp - Ordinary Shares Class A stock price yesterday?
What is the PE ratio of Immuneering Corp - Ordinary Shares Class A?
What is the Price-to-Book ratio of Immuneering Corp - Ordinary Shares Class A?
What is the 50-day moving average of Immuneering Corp - Ordinary Shares Class A?
How many employess does Immuneering Corp - Ordinary Shares Class A has?

Latest IMRX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.